| 000 | 01775 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515035739.0 | ||
| 264 | 0 | _c20061204 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a1078-0432 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-06-0171 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJuarez, Jose C | |
| 245 | 0 | 0 |
_aCopper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cAug 2006 |
||
| 300 |
_a4974-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCopper _xmetabolism |
| 650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 1 _xmetabolism |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 3 _xmetabolism |
| 650 | 0 | 4 |
_aMolybdenum _xpharmacology |
| 650 | 0 | 4 |
_aMultiple Myeloma _xblood supply |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSuperoxide Dismutase-1 |
| 700 | 1 | _aBetancourt, Oscar | |
| 700 | 1 | _aPirie-Shepherd, Steven R | |
| 700 | 1 | _aGuan, Xiaojun | |
| 700 | 1 | _aPrice, Melissa L | |
| 700 | 1 | _aShaw, David E | |
| 700 | 1 | _aMazar, Andrew P | |
| 700 | 1 | _aDoñate, Fernando | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 12 _gno. 16 _gp. 4974-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-06-0171 _zAvailable from publisher's website |
| 999 |
_c16501605 _d16501605 |
||